Great contributions from Ferenc Fenyvesi, Ildikó Bácskay (University of Debrecen) and Milo Malanga PhD (CarboHyde)
This has been one of the most fluorishing relationships of our company with many interesting and groundbreaking common projects we will share in the future.
The most anticipated pharmaceutical event of the year is fast approaching! CPHI 2024, set to take place in Milan from October 8-10, is the world’s largest pharmaceutical exhibition. This event is a unique convergence of six individual pharma sectors, covering every aspect of the industry—from ingredients and FDF to machinery, packaging, outsourcing, and biopharmaceuticals.
This year’s CPHI is shaping up to be bigger and better than ever. Here’s what attendees can look forward to:
For those who have previously attended a CPHI event, you’ll know that it’s tailored specifically for professionals in the pharmaceutical industry. Whether you’re looking to network, learn, or explore new business opportunities, CPHI is the place to be.
Among the myriad of products and technologies on display, cyclodextrins will feature prominently at CPHI 2024. Expect to meet a wide range of users and manufacturers of cyclodextrins, including:
And, of course, CarboHyde will be there too. Our team will be well-represented, with CFO Gergely Toth, COO Tamás Vargadi, and Tamas Sohajda all attending the event. We’re excited about the opportunity to engage with industry peers and discuss potential collaboration on cyclodextrin projects.
If you’re planning to attend CPHI in Milan, we would love to catch up with you. This event presents a fantastic opportunity to plan and strategize around cyclodextrin-related projects. We believe that face-to-face interactions at such a prestigious event can pave the way for meaningful collaborations.
We look forward to seeing you there!
Johannesburg, South Africa, and Budapest, Hungary – [28/08/2024] – The University of the Witwatersrand (WITS), a leading research institution in South Africa, and CarboHyde Zrt, a pharmaceutical company based in Hungary, have entered into a strategic collaboration to advance the development of a novel breast cancer therapeutic. This partnership aims to accelerate the development of this asset further while securing funding opportunities within Europe and ensuring the successful progress of this promising therapeutic from research to market.
The collaboration between WITS and CarboHyde will be executed in multiple phases: first, finishing the preclinical studies, and later, starting clinical trials together or with other partners.
This collaboration marks a significant milestone in the fight against breast cancer, combining the strengths of two innovative organizations across continents. By pooling their resources, expertise, and networks, WITS and CarboHyde aim to bring this cutting-edge therapeutic to market, benefiting patients and healthcare systems worldwide.
For more information, please contact CarboHyde at info@carbohyde.com
About the University of the Witwatersrand: The University of the Witwatersrand (WITS) is a leading research-intensive institution based in Johannesburg, South Africa. WITS is dedicated to advancing knowledge through impactful research and is recognized globally for its contributions to science and innovation.
About CarboHyde Zrt: CarboHyde is a pharmaceutical company based in Budapest, Hungary, specializing in carbohydrate chemistry, including cyclodextrins. CarboHyde focuses on creating innovative solutions and collaborating with partners worldwide to bring breakthrough technologies to market in the pharmaceutical arena.
Unbelievable, but it has been 191 days since we had the full CarboHyde team together in person.
After completing 3 Bicyclos HEurope secondments, now we will enjoy a few months together before we depart again in the fall.
Now that Kristof is back too, he focuses on finishing his PhD and just tackled his practical defence.
Our next free webinar, titled “Cyclodextrin formulations: The Journey from the Benchtop to the Patients” brings together experts who will guide us through the milestones of this remarkable journey.
Event Overview: Join us for an illuminating webinar that traces the evolution of cyclodextrin-based drug delivery systems—from laboratory research to real-world patient care. Our esteemed speakers will explore key aspects of this journey, highlighting breakthroughs, challenges, and the promise of cyclodextrins in improving therapeutic outcomes.
Link for registration: https://www.congress-service.hu/rendezveny/cyclodextrinwebinar2024
Time&Date: September 26., 2024, 3 pm – 5 pm (CEST, Budapest time)
We still have a few seats open for this fantastic event we are organizing together with Eötvös Loránd University under the frame of the Bicyclos HEurope project.
A 2,5-day workshop in September 2024 in the lovely Budapest, dealing with New approaches to sustainable synthetic chemistry of carbohydrates and derivatives.
Our target audience are undergrad and PhD students, yet industry professionals and any carbohydrate/cyclodextrin beginners are more than welcome. Learn more about the event: https://lnkd.in/gbHUg-DX
Register: https://lnkd.in/dZsis8UW
It will be stunning!
Our next free webinar, titled “Cyclodextrin formulations: The Journey from the Benchtop to the Patients” brings together experts who will guide us through the milestones of this remarkable journey.
Event Overview: Join us for an illuminating webinar that traces the evolution of cyclodextrin-based drug delivery systems—from laboratory research to real-world patient care. Our esteemed speakers will explore key aspects of this journey, highlighting breakthroughs, challenges, and the promise of cyclodextrins in improving therapeutic outcomes.
Link for registration: https://www.congress-service.hu/rendezveny/cyclodextrinwebinar2024
Time&Date: September 26., 2024, 3 pm – 5 pm (CEST, Budapest time)
Agenda:
Who Should Attend: Researchers, clinicians, pharmaceutical professionals, and anyone curious about the journey of cyclodextrins—from lab discoveries to patient impact.
Don’t miss this opportunity to explore the bridge between science and healing. Register now and join the cyclodextrin revolution!
I would be delighted to hear suggestions for upcoming topics and engage in Q&A, so please feel free to add your impressions in the comments or via email at tamas.sohajda@carbohyde.com. Thank you.
In the coming weeks, we will continue focusing on using cyclodextrins as active ingredients, disease by disease. Stay tuned!
A small CarboHyde delegation (Kristóf Felegyi and Balázs Attila Kondoros) is just starting their Bicyclos HEurope secondment in Santiago de Compostella under the fantastic support of Angel Piñeiro & Rebeca Garcia-Fandino.
Hopefully this short time will be enough for the guys to learn the basics of molecular modeling and do some fancy cyclodextrin stuff on their own.
Kristóf Felegyi just completed CarboHyde’s very first secondment under the scope of the Bicyclos HEurope project under the strong support of Csenge Anna Felegyi-Tóth.
Kristof worked for 5 months in the lab of Jose Manuel Garcia Fernandez under the supervision of Juanma Benito and created various cyclodextrin polymers that we will evaluate for gene and small molecule delivery.
😎
We appreciate the strong support and hospitality of CSIC and look forward to further collaborations.
As Kristof did not take a single photo in the lab, we can only trust he did not only do sightseeing in the wonderful city
CarboHyde CEO Tamas Sohajda recently delivered a compelling presentation at the CPHI North America conference, focusing on innovative applications of cyclodextrins in the pharmaceutical industry. His talk highlighted how these unique cyclic oligosaccharides can enhance drug delivery, improve solubility, and stabilize formulations, offering significant benefits to pharmaceutical development.
Cyclodextrins, known for their ability to form inclusion complexes with various molecules, have been extensively studied for their potential to revolutionize drug formulations. Sohajda’s presentation delved into recent advancements and case studies demonstrating the successful integration of cyclodextrins in new drug delivery systems. These developments promise to improve the efficacy and safety of numerous medications, addressing longstanding challenges in drug formulation and bioavailability.
The talk received considerable attention from industry professionals, underscoring CarboHyde’s leading role in pioneering the use of cyclodextrins for pharmaceutical innovation. Attendees had the opportunity to engage with Sohajda, discussing cyclodextrin research’s practical applications and future directions.
A video of the event is available on CPHI website – after a registration – for those who missed the presentation or wish to revisit the insights shared.
CPHI: Lightning Round: Excipients 4.0 – Cyclodextrins (CDs) (video) (cphi-online.com)
On Vimeo:
Dr Tamas Sohajda Lightning Round Excipients 4.0 – Cyclodextrins CDs on Vimeo
Stay tuned for more updates from CarboHyde as they continue to push the boundaries of pharmaceutical technology.
Today’s #yclodextrin is about the fantastic progression of the GENEGUT project CarboHyde is part of.
The 5th in-person General Assembly meeting was kindly hosted by our partners at i3S – Instituto de Investigação e Inovação em Saúde, Bruno Sarmento, Catarina Leite Pereira in Porto, PT 🚀
We (Kristóf Felegyi) reported the chemistry work, which was our part, and now look forward to seeing how these building blocks will perform in RNA delivery and eventually in drug formulation. Caitriona O’Driscoll and Ana Francisca Soares presented some of the promising data at the 21st International Cyclodextrin Symposium last week.
We look forward to interesting discussions, progress updates and networking within the GENEGUT consortium 💡
Last week between 10-14 June, the cream of cyclodextrin science gathered in Dunkerque, France to share their knowledge and most recent scientific results during the 21st International Cyclodextrin Symposium.
The conference started with a social tour, visiting nearby sights on the seashore and harbor and spending a wonderful lunch together. We concluded the first-day networking with a welcome party at the Town Hall.
During the event, we could enjoy 81 oral presentations spread across a 3 and half-day scientific fiesta. 166 participants from all around the world (75% Europe, 15% Asia, 10% America) exchanged ideas and initiated collaborations. The most well-represented countries were France, Italy, and Hungary (:P).
During the breaks, we could enjoy bites from French cuisine and discuss further science through the 56 presented posters.
The 1st day was topped by a huge Dunkerque beer&cheese carnival, one of the most memorable social events of all time, while the 2nd one with a wonderful Gala dinner at the stunning nearby aquarium.
CarboHyde was represented by two members, Daniel Bisericaru and Tamas Sohajda, and presented a talk about the status, future and dilemmas of developing cyclodextrin-based active ingredients. Further collaborations of the company were dominated by sharing the results of two EU-funded projects: GENEGUT & Bicyclos HEurope.
Several awards were presented during the Symposium:
The conference was concluded by sharing future events where professionals can meet again:
I hope to see many of you during these events!
It was an amazing experience, huge thanks to the organizers Sophie Fourmentin, Eric MONFLIER and Bernard Martel for their excellent work.
Best wishes, Tamas